Skip to main content
Fig. 7 | BMC Complementary Medicine and Therapies

Fig. 7

From: Sodium selenite preserves rBM-MSCs’ stemness, differentiation potential, and immunophenotype and protects them against oxidative stress via activation of the Nrf2 signaling pathway

Fig. 7

Western blot comparison of signaling molecules in response to Sodium Selenite (0.1 µM) in the rBM-MSCs. Expression of Nrf-2 and Selenium dependant antioxidant enzymes, such as SOD, GPX, and TrxR, increased compared with the control group. The level of AKT, P, increased after 72 h treatment with 0.1 µM sodium selenite. Data are represented as mean ± SD* p < 0.05, ** p < 0.01 significant level of treatment (T) vs. control (C) group. C1,2, and 3 are the three replicates of the control groups and T1,2, and 3 are three replicates of selenium (0.1 µM)treatment group. Full length blots are presented in the supplementary data. Number of samples = 3, Data: Mean ± SD

Back to article page